BASF's enhanced €11 billion Evonik bid faces rejection

BASF's increased €11 billion takeover proposal for Evonik is set to be rejected, per the Financial Times. The move signals Evonik's board considers the offer too low, raising the prospect of a higher bid or a collapse of the deal. A successful acquisition would create a chemicals giant, but antitrust hurdles loom.